Synthetic Biology Market (By Technology: PCR Technology, NGS Technology, Bioprocessing Technology, Genome Editing Technology, Other Technologies; By Product: Enzymes, Oligonucleotide/Oligo Pools and Synthetic DNA, Xeno-Nucleic Acids, Cloning Technologies Kits, Chassis Organism; By Application: Healthcare, Non-healthcare; By End-Use) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Synthetic Biology Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Synthetic Biology Market, by Technology, 2024-2033
8.1.1. PCR Technology
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. NGS Technology
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Bioprocessing Technology
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Genome Editing Technology
8.1.4.1. Market Revenue and Forecast (2021-2033)
8.1.5. Other Technologies
8.1.5.1. Market Revenue and Forecast (2021-2033)
9.1. Synthetic Biology Market, by Product, 2024-2033
9.1.1. Enzymes
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Oligonucleotide/Oligo Pools and Synthetic DNA
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Xeno-Nucleic Acids
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. Cloning Technologies Kits
9.1.4.1. Market Revenue and Forecast (2021-2033)
9.1.5. Chassis Organism
9.1.5.1. Market Revenue and Forecast (2021-2033)
10.1. Synthetic Biology Market, by Application, 2024-2033
10.1.1. Healthcare
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Non-healthcare
10.1.2.1. Market Revenue and Forecast (2021-2033)
11.1. Synthetic Biology Market, by End-Use, 2024-2033
11.1.1. Academic and Government Research Institutes
11.1.1.1. Market Revenue and Forecast (2021-2033)
11.1.2. Biotechnology and Pharmaceutical Companies
11.1.2.1. Market Revenue and Forecast (2021-2033)
11.1.3. Others
11.1.3.1. Market Revenue and Forecast (2021-2033)
12.1. North America
12.1.1. Market Revenue and Forecast, by Technology (2021-2033)
12.1.2. Market Revenue and Forecast, by Product (2021-2033)
12.1.3. Market Revenue and Forecast, by Application (2021-2033)
12.1.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Technology (2021-2033)
12.1.5.2. Market Revenue and Forecast, by Product (2021-2033)
12.1.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.1.5.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Technology (2021-2033)
12.1.6.2. Market Revenue and Forecast, by Product (2021-2033)
12.1.6.3. Market Revenue and Forecast, by Application (2021-2033)
12.1.6.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Technology (2021-2033)
12.2.2. Market Revenue and Forecast, by Product (2021-2033)
12.2.3. Market Revenue and Forecast, by Application (2021-2033)
12.2.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Technology (2021-2033)
12.2.5.2. Market Revenue and Forecast, by Product (2021-2033)
12.2.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.2.5.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Technology (2021-2033)
12.2.6.2. Market Revenue and Forecast, by Product (2021-2033)
12.2.6.3. Market Revenue and Forecast, by Application (2021-2033)
12.2.6.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Technology (2021-2033)
12.2.7.2. Market Revenue and Forecast, by Product (2021-2033)
12.2.7.3. Market Revenue and Forecast, by Application (2021-2033)
12.2.7.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Technology (2021-2033)
12.2.8.2. Market Revenue and Forecast, by Product (2020-2032)
12.2.8.3. Market Revenue and Forecast, by Application (2021-2033)
12.2.8.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Technology (2021-2033)
12.3.2. Market Revenue and Forecast, by Product (2021-2033)
12.3.3. Market Revenue and Forecast, by Application (2021-2033)
12.3.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Technology (2021-2033)
12.3.5.2. Market Revenue and Forecast, by Product (2021-2033)
12.3.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.3.5.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Technology (2021-2033)
12.3.6.2. Market Revenue and Forecast, by Product (2021-2033)
12.3.6.3. Market Revenue and Forecast, by Application (2021-2033)
12.3.6.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Technology (2021-2033)
12.3.7.2. Market Revenue and Forecast, by Product (2021-2033)
12.3.7.3. Market Revenue and Forecast, by Application (2021-2033)
12.3.7.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Technology (2021-2033)
12.3.8.2. Market Revenue and Forecast, by Product (2021-2033)
12.3.8.3. Market Revenue and Forecast, by Application (2021-2033)
12.3.8.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Technology (2021-2033)
12.4.2. Market Revenue and Forecast, by Product (2021-2033)
12.4.3. Market Revenue and Forecast, by Application (2021-2033)
12.4.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Technology (2021-2033)
12.4.5.2. Market Revenue and Forecast, by Product (2021-2033)
12.4.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.4.5.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Technology (2021-2033)
12.4.6.2. Market Revenue and Forecast, by Product (2021-2033)
12.4.6.3. Market Revenue and Forecast, by Application (2021-2033)
12.4.6.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Technology (2021-2033)
12.4.7.2. Market Revenue and Forecast, by Product (2021-2033)
12.4.7.3. Market Revenue and Forecast, by Application (2021-2033)
12.4.7.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Technology (2021-2033)
12.4.8.2. Market Revenue and Forecast, by Product (2021-2033)
12.4.8.3. Market Revenue and Forecast, by Application (2021-2033)
12.4.8.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Technology (2021-2033)
12.5.2. Market Revenue and Forecast, by Product (2021-2033)
12.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.5.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Technology (2021-2033)
12.5.5.2. Market Revenue and Forecast, by Product (2021-2033)
12.5.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.5.5.4. Market Revenue and Forecast, by End-Use (2021-2033)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Technology (2021-2033)
12.5.6.2. Market Revenue and Forecast, by Product (2021-2033)
12.5.6.3. Market Revenue and Forecast, by Application (2021-2033)
12.5.6.4. Market Revenue and Forecast, by End-Use (2021-2033)
13.1. Codexis, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Bota Biosciences Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Creative Enzymes.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Creative Biogene.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Illumina, Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Enbiotix, Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. New England Biolabs
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Merck Kgaa (Sigma-Aldrich Co. Llc)
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Novozymes
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Euro fins Scientific
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample